- Home
- Articles
- us virgislands
- disease patient
Refine by
Disease Patient Articles & Analysis
145 articles found
Central to this phase is the use of appropriate disease models, which are essential for understanding the mechanisms of disease and assessing the efficacy and safety of experimental compounds. ...
A New Drug to Reduce Heart Attacks and Strokes The newly approved drug Sotagliflozin (Inpefa) has shown promise in reducing heart attacks and strokes among patients with type 2 diabetes and chronic kidney disease. It works as a dual SGLT1 and SGLT2 inhibitor, helping to regulate blood sugar levels while also protecting the heart. Clinical trials demonstrated a ...
This precision targeting is critical for treating diseases such as cancer, where minimizing damage to healthy tissues while aggressively targeting cancerous cells is paramount. ...
However, their natural capacity may not always be sufficient to combat complex diseases. This limitation has sparked interest in utilizing gene editing to enhance T cell functionality. ...
Glycated collagen mainly exists in various tissues in the human body, especially those rich in collagen, such as skin, bones, joints, blood vessels, and other connective tissues.Under normal physiological conditions, glycation occurs as a natural biochemical process, but its degree is usually low. In certain disease states, especially in patients with diabetes, ...
These differences may lead to different susceptibilities to diseases, drug responses, and treatment effects. With this technology, doctors can more accurately assess the disease status of patients, predict the trend of disease progression, and formulate more personalized treatment plans, improve treatment effects and reduce side ...
Although frontline treatment of chemotherapy and surgery is often effective, with nearly all patients experiencing remission, over 80% of patients will experience disease recurrence in the first two years and ultimately die of the disease. ...
One of the biggest challenges clinical data management faces is the sheer amount of data that needs to be processed. With more and more patient data becoming available, it can be difficult for CDM systems to keep up. ...
ByClinion
The development of monoclonal antibodies (mAbs) has completely transformed the field of medicine, providing targeted antidotes against a wide range of diseases, including cancer, autoimmune and infectious diseases. These therapeutic antibodies aim to specifically target antigens on the surface of cells and bind to them, leading to acidic reactions that result in ...
AAV vectors are used as delivery vehicles or "vectors" to administer therapeutic genes into patient's cells. This therapeutic gene, once inside the cell, generates a functional protein to correct or counter the effects of the disease-causing genetic mutation, providing a basis for curing several genetic diseases. ...
Rare diseases, also known as orphan diseases, affect a small percentage of the population, making them particularly challenging to diagnose and treat. ...
Abnormalities in Chromosome Number More or less chromosomes can lead to the occurrence of some rare diseases. Patients with Down syndrome show abnormal mental development and multiple organ malformations due to the presence of an extra chromosome 21. ...
This technology has enabled healthcare professionals to pinpoint the cause of rare diseases more accurately and tailor treatments specific to each patient's genetic makeup. ...
Patients who need medical treatment often fear being exposed to harmful germs and unsanitary instruments. ...
Patients with other rheumatologic diseases were generally negative for ACA with a few exceptions, such as those with RA overlap syndromes. ...
Influenza A virus, strain: A/Puerto Rico/8/1934 (H1N1) was obtained from Friedrich-Loeffler-Institute, Federal Research Centre for Virus Diseases of Animals, Tuebingen, Germany, and passaged on MDCK II cells in a BSL 2 laboratory. ...
The field of medical science has long utilized disease models, which are systems simulating the progression and expression of a disease, to better understand various illnesses. ...
The field of medical science has long utilized disease models, which are systems simulating the progression and expression of a disease, to better understand various illnesses. ...
When studying gene expression, researchers often compare gene expression profiles between different biological samples or experimental conditions, such as healthy and diseased tissues, treated and untreated cells, or different developmental stages. ...
By profiling patient samples using scRNA-seq, researchers can identify cell types that are relevant to the disease and develop more accurate disease models. ...